BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 News By Date

SuMoTuWeThFrSa
2829301234
567891011
12131415161718
19202122232425
2627282930311
2345678

 Monday, October 20, 2014
 Top Breaking News
Ebola Clinical Trials: Big Name Players In The Ebola Race
Genentech (RHHBY), NewLink Genetics Strike $1 Billion+ Cancer Deal
Allergan Inc. (AGN) Chops Jobs In Carlsbad
Biotech Startup Factory PureTech Nabs $55 Million
Shire Goes Shopping After AbbVie (ABBV) Deal Falls Through
Amgen (AMGN) Will Assign 12 To 14 Staff Members To Look Into An Alternative Production Method For Mapp Biopharmaceutical's ZMapp
Ranbaxy Laboratories (RANBAXY.BO)’ Staff Get Pay-Cut Shield In Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Buyout
Forendo Licenses U.S. Fispemifene Rights To Apricus Biosciences (APRI) In Deal Worth $305 Million
TesoRx, Aspen Group Ink $95 Million Pact
Neothetics Files To Raise $63 Million To Fight Fat With An Asthma Drug
Shire's Finance Chief Jumps Ship
FDA Panel Unanimously Backs Novartis AG (NVS)' Psoriasis Drug
Government Of Canada Ships NewLink Genetics' Ebola Vaccine To The WHO
Regeneron (REGN)'s EYLEA® Tops Rivals In Study
Regeneron (REGN), Sanofi (SAN.PA) Begin Pivotal Phase 3 Study For Eczema Drug Dupilumab
Xenon Pharmaceuticals Inc. Postpones IPO
Fresenius AG, Buyout Groups Eye Danone Medical Nutrition Unit
Redag Crop Protection To Create 20 R&D Jobs
Therapix Biosciences Names Jan Turek CEO
Cubist Pharmaceuticals, Inc. (CBST) Brings In Ex-Biogen Idec (BIIB) Exec For CEO Post
BaseHealth Names Former Illumina, Inc. (ILMN) Executive Jorge Velarde As New CEO And President
 Featured Stories
 More News
Halozyme Therapeutics, Inc. (HALO) Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant
Pfizer (PFE) Release: FDA Approves Abuse Deterrent Labeling For EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII
China Biologic Products Awarded CFDA Approval To Manufacture Plasma Product
Eisai Inc. (ESALF.PK) Announces FDA Acceptance Of Supplemental New Drug Application For Antiepileptic Drug Perampanel As Adjunctive Treatment Of Primary Generalized Tonic-Clonic Seizures
Pharmacyclics, Inc. (PCYC) Files Supplemental New Drug Application For IMBRUVICA® For Waldenstrom's Macroglobulinemia
Janssen Research & Development Release: IMBRUVICA® (ibrutinib) Supplemental New Drug Application Submitted To The U.S. FDA For Waldenstrom's Macroglobulinemia
FDA Accepts For Review A Biologics License Application For Merck & Co. (MRK) And Sanofi Pasteur (SASY.PA)’s Investigational Pediatric Hexavalent Vaccine
Matinas BioPharma Submits Investigational New Drug Application For Lead Product Candidate MAT9001 For The Treatment Of Severe Hypertriglyceridemia
Clanotech Receives Orphan Drug Designation In The EU
Cytokinetics, Inc. (CYTK) Provides Development Program Update For Tirasemtiv
Results From Two Phase 3 Studies Added To U.S. Label Of Genzyme’s Aubagio
Amicus Therapeutics, Inc. (FOLD) Announces Additional Positive Phase 3 Data From Fabry Monotherapy Study 011
ChemoCentryx, Inc. (CCXI) Releases Phase 3 SHIELD 4 Clinical Results In Patients With Crohn's Disease
Taiho Oncology Receives D&A Pharma Fast Track Designation For TAS-102 As A Potential Treatment For Refractory Metastatic Colorectal Cancer
RegeneRx Biopharmaceuticals, Inc. (RGRX) Allowed To Proceed With Phase 3 Using RGN-259 Eye Drops For The Treatment Of Neurotrophic Keratopathy
Milo Biotechnology's Follistatin Gene Therapy Increases Function In Becker Muscular Dystrophy Patients
Immunomedics, Inc. (IMMU) Announces European Orphan Drug Designation For Isactuzumab Govitecan For Pancreatic Cancer Treatment
Norgine Release: Positive Results From Phase 2 Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy
CytRx Corporation (CYTR) Announces Publication Of Phase 1b/2 Aldoxorubicin Clinical Data In Soft Tissue Sarcoma In Cancer, The Peer-Reviewed Journal Of The American Cancer Society
Genervon Announces ALS And PD Phase 2a Trial Results
AgonOx’s OX40 Platform Being Utilized In MedImmune (AZN)’s Phase 1 OX40 Agonist Study
R-Tech Ueno: Announcement Of Initiation Of The Phase I Clinical Trial For The Novel VAP-1 Inhibitor RTU-1096
Galapagos NV (GLPG.BR) Discloses Novel Target And Presents Favorable Phase 1 Data For GLPG1205 At UEG Week
VG Life Sciences, Inc. (VGLS) Release: New Data Implicate Components Of Adaptive Immunity In Traumatic Brain Injury
American Academy of Ophthalmology Release: Research Reveals Likelihood And Onset Of Multiple Sclerosis Diagnosis Among Patients With Inflammatory Eye Disease
International Osteoporosis Foundation Release: Survey Shows 90% Of Adults Unaware Of Men's Risk For Osteoporosis
The Parkinson Alliance Release: Autonomic Dysfunction In Parkinson's Disease With And Without Deep Brain Stimulation
National Osteoporosis Foundation Release: New Research Shows 93 Percent Of U.S. Adults Unaware Of Men's Risk For Osteoporosis
APR Applied Pharma Research S.A. Release: Newly Released Data On Nexodyn™ In The Management Of Chronic Wounds At The Fall Symposium Of Advanced Wound Care (SAWC) In Las Vegas, NV (15-18 October 2014)
Revalesio's RNS60 Demonstrates Promise In Treating Alzheimer's Disease And Other Dementias
New Ohio State University Study Seeks To Treat Children With ADHD By Retraining Their Brains
Children's Hospital of Philadelphia Release: New Treatment Reported For A Potentially Fatal Lymphatic Complication In Children With Heart Disease
Cypher Genomics Identifies And Verifies Genetic Cause Of Rare Disease, Epileptic Encephalopathy
BioProcess Technology Consultants, Inc. Acquires CTD Quality Consulting, Launches New advanceONE™ Division
Calixar And Aston University Together In Collaborative Research To Tackle Multidrug Resistance Targets
Clean TeQ Holdings Limited (ASX:CLQ) And SIDRI Sign Heads Of Agreement
Sirona Biochem Announces Research Collaboration With Aegilops Applications
Hemispherx Biopharma (HEB) Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola
The Hereditary Neuropathy Foundation And BioPontis Alliance For Rare Disease Partner To Develop Treatments For Charcot-Marie-Tooth
Affymetrix (Santa Clara, California) (AFFX) Exclusively Licenses Technology From Peptide Groove LLP For HLA Typing From Genotyping Data
New England Biolabs, Inc. And Directed Genomics Partner To Develop Novel Target Enrichment Technologies For Next Generation Sequencing
Nuvilex (NVLX) Contracts With University Of Veterinary Medicine In Vienna To Conduct Preclinical Studies On The Use Of Cell-In-A Box® To Develop Diabetes Treatment
Apricus Biosciences (APRI) Expands Development Pipeline With The In-Licensing Of U.S. Rights For Fispemifene, A Phase 2b Ready Asset, From Forendo Pharma Targeting Urological Conditions In Men
Neptune Technologies & Bioressources Inc. And BlueOcean Sign Licensing Agreement
Humacyte, Inc. Selected To Join U.S. Secretary Of Commerce On Trade Mission To Asia
Asterias Biotherapeutics Announces Notice Of Grant Award With CIRM For Phase 1/2a Clinical Trial Of AST-OPC1 In Complete Cervical Spinal Cord Injury
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults
Admedus Cardiocel® To Be Launched In Canada
Baxter International, Inc. (BAX) Launches HYQVIA In The United States For Adult Patients With Primary Immunodeficiency
ERYtech Pharma Announces Granting Of New Patent In The United States
Lpath, Inc. (LPTN) Granted Key European Patent Related To iSONEP And ASONEP Programs
Acasti Pharma Announces Grant Of Stock Options
DBV Technologies Announces Proposed Global Offering
Celgene (CELG) Participates In New Round Of Investment For Sequenta, Inc.
DiaGenic ASA: Change Of Company Name Registered In The Register Of Business Enterprises
DiaGenic ASA: Share Capital Increase Registered
Meta-IQ Engages Back Bay Life Science Advisors In Preparation For Investment
Personalis Introduces New Services For Cancer Research And Clinical Trials
Cancer Research Technology Introduces Ximbio, An Online Reagents Portal
Almac Group Introduce Flexible Clinical Trial Direct To Patient Solution
Lion Biotechnologies, Inc. CSO Laszlo Radvanyi Co-Authors Study In Journal Of Immunotherapy
InVivo Therapeutics Corporation (NVIV) Announces Barnes-Jewish Hospital At InVivo Therapeutics Corporation (NVIV) As New Clinical Trial Site For Neuro-Spinal Scaffold
Advisory - Health Canada Seizes Dangerous Health Products From Online Retailer
ViiV Healthcare Expands Program To Reduce HIV Disparities In Southern U.S.
Galapagos NV (GLPG.BR) Creates New Warrant Plan
The NextCode Health Exchange: The First Global, Real-Time System For Sharing Full-Resolution Genomic Data
Nano-Bio Manufacturing Consortium Selects Project Proposed By Arizona Center For Integrative Medicine To Optimize Human Performance Monitoring Techniques
Hemispherx Biopharma (HEB) Prevails In Multi-Million Dollar Federal Lawsuit
Pharmaceutic Labs Opens CGMP Outsourcing Facility In Albany, NY
Thermo Fisher Scientific (TMO) Release: New Digital PCR-Based Research Solution Characterizes Hard-To-Detect Cancer Mutations
Purolite Life Sciences Introduces High-Resolution Agarose Based Chromatography Resins For Protein Purification
Thermo Fisher Scientific (TMO) Release: New Orbitrap-Based Mass Spectrometer Makes High-Resolution Accurate-Mass Analysis Widely Accessible
Tosoh Bioscience, Inc. Introduces CaPure-HA
Radiant Sage Announces Corelab-in-a-Box Version 3.1
Lab7 Systems Launches The Enterprise Sequencing Platform™ (ESP) For Comprehensive Sample-to-Answer Management Of Genome Sequencing Data
Bio-Rad Laboratories, Inc. (BIO) Adds New PrimePCR™ Assays For Droplet Digital™ PCR
BioDiscovery, Inc. Launches NxClinical™ For Complete Case Review And Reporting For Genetics Labs
Amgen (AMGN) Announces 2014 Fourth Quarter Dividend
CTI BioPharma To Report Third Quarter 2014 Financial Results On October 29, 2014
IGI Laboratories, Inc. To Hold Conference Call For 3rd Quarter 2014 Results
Valeant (VRX) Reports Third Quarter 2014 Financial Results
Epic Sciences Appoints Michael Giske As Chief Information Officer
AnaptysBio, Inc. Appoints Dr. Marco Londei To Newly Created Chief Development Officer Position Clinical Immunologist To Lead Anaptysbio's Pipeline Advancement
Advaxis, Inc. Appoints David J. Mauro, M.D., Ph.D., As Chief Medical Officer
23andMe, Inc. Appoints Ruby Gadelrab Vice President Of Commercial Marketing
Revalesio Names Bert van den Bergh President
Aesica Appoints VP, Business Development And Business Development Director For Finished Dose To Drive Service In Europe And Achieve Further Growth
Advanced Cell Technology Appoints Leroux Jooste As SVP Of Business Development & Chief Commercial Officer
Amgen (AMGN) Announces Appointment Of R. Sanders Williams To Board Of Directors
BBB Therapeutics Appoints Jan Van Heek As Chairman Of The Supervisory Board
Gen9 Expands Global Market Development Team With New Senior Appointments
Zola P. Horovitz To Retire From GenVec Inc. (GNVC) Board
UT Southwestern Medical Center Neuroscience Chair Dr. Joseph Takahashi Elected To National Academies Of Sciences' Institute Of Medicine
Proteostasis Therapeutics, Inc. Announces Appointments Of Cystic Fibrosis Experts To Inaugural Clinical Advisory Board
BioNova Release: BioPort Atlantic 2014 Kicks Off Today
Bay Area Lyme Foundation Requests Proposals For $100,000 Grant For National Emerging Leader In Lyme Research
Abbott Laboratories (ABT) Release: New Large-Scale Study Will Look At How Nutrition Can Help Keep Patients From Returning To The Hospital
Meehl Foundation's Debra Meehl To Present Informative, Interactive Bipolar And Borderline Personality Disorder Workshop At Amen Clinic In Atlanta
NextCode Health, Simons Foundation To Speed Autism Research With Real-Time Access To 10,000 Exomes
Derma Sciences, Inc. (DSCI) Showcases "Off-Loading Your Diabetic Foot Ulcer, An Actor's Story," A Patient Video Featuring Actor And Director Stephen Furst And His Experience With TCC-EZ®
Sonoco ThermoSafe Survey Reveals Future Needs, Trends of Cold Chain Industry
Alnylam Pharmaceuticals (ALNY) Launches Alnylam Assist™, Dedicated To Providing Support To Patients, Families, And Caregivers In Certain Genetic Diseases
Colorado BioScience Association Honors Industry’s Best At 2014 Awards Dinner, Featuring Keynote By Olympic Medalist & Parkinson’s Survivor Davis Phinney
Hudson-Alpha Institute for Biotechnology Named Latest RainDance Center Of Excellence
Emergent BioSolutions (EBS) To Webcast Presentation At Credit Suisse 2014 Healthcare Conference
Medigus (MDGS.TA) To Present Data On MUSE™ Combined With Peroral Treatment Of Achalasia At United European Gastroenterology Week 2014
Phase 2 Data For Progenics Pharmaceuticals, Inc. (PGNX)' 1404 Imaging Agent Presented At EANM Congress
Ohr Pharmaceutical (OHRP) Announces New Positive Anatomic And Visual Acuity Data On OHR-102 (Squalamine Eye Drops) IMPACT Study Presented At The 2014 American Academy of Ophthalmology Scientific Meeting
Pacific Biosciences (PACB) Sequencing For Allele-Specific HLA Typing To Be Showcased At American Society For Histocompatibility And Immunogenetics (ASHI) Annual Meeting
Phase 2 Data In Crohn’s Disease For Celgene (CELG)’s Oral Antisense Therapy GED-0301 To Be Presented At UEG Week 2014
Mologen AG (MOLGF.PK): Successful Investigator Meetings For IMPALA Colorectal Cancer Trial
IBC Life Sciences Release: Bioprocess International (BPI) 2014 Opens Its Doors To More Than 1500 Industry Leaders Seeking New Technologies, Partnerships, And Critical Insights
Opexa Therapeutics (OPXA) To Present At Cleveland Clinic’s 12th Annual Medical Innovation Summit
Industry’s Shifting Paradigms & Rise Of The Entrepreneur Focus For Inaugural Dohmen Life Science Services Entrepreneur Summit, Oct. 21-22, 2014
Mucosis B.V. Presents Data On Intranasal RSV Vaccine SynGEM® At Vaccines 2014 Conference
Ironwood Pharmaceuticals (IRWD) Presents IW-9179 Phase 2a Data At American College of Gastroenterology 2014 Annual Scientific Meeting
Pilgrim Co-Sponsors FDAnews Conferences To Emphasize Best Practices In Life Sciences
New Research Published On JoVE Demonstrates Successful Lifecycle Modeling Of Ebola Virus In Biosafety Level 2 Conditions
Pathway Genomics Corporation Launches Patient Mobile App At American Society of Human Genetics 2014
QIAGEN N.V. (QGEN) Demonstrates Expanded Bioinformatics Workflows At American Society of Human Genetics; Strong Market Adoption As Researchers Analyze Genomic Data On More Than A Quarter-Million Samples In Secure Private Cloud